Home RxNorm 2398133 Polivy 30 MG Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2398133
RxNorm name Polivy 30 MG Injection
Display name Polivy 30 MG Injection
Full name Polivy 30 MG Injection
Term type SY
Status DailyMed mapping
Updated 2026-06-04 23:38:50 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761121 Polivy polatuzumab vedotin-piiq 351(a) Rx 2026-08-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 20a16ab2-f338-4abb-9dcd-254bd949a2bc Polivy 30 MG Injection [PSN] · polatuzumab vedotin-piiq 30 MG Injection [Polivy] [SBD] · Polivy 30 MG Injection [SY] 3 14 These highlights do not include all the information needed to use POLIVY safely and effectively. See full prescribing information for POLIVY. POLIVY ® (polatuzumab vedotin-piiq) for injection, for intravenous use Initial U.S. Approval: 2019 20260324